National Geroscience Initiative
Symposium Agenda
3.5 Hours
10 minutes
Paul Pasquina, MD, Chair, PM&R, USUHS
Welcome and introduction of conference moderator and hosts
10 minutes
Dr. Richard W. Thomas, President
Uniformed Services University
Welcome and Introduction of
Senator Chris Van Hollen
10 minutes
Senator Chris Van Hollen
The Importance of Health Science Research
July 12, 2025
Section 1: Background: Aging, the Geroscience Hypothesis and the Symposium
Schedule Item Body
5 minutes
William K. Smith MD
Assistant Professor, USUHS, University of South Carolina
Background and Mission of the Symposium
10 minutes
Charlotte Yeh, MD, Chief Medical Officer, AARP
The Challenge of Aging
10 minutes
Ronald A. Kohanski, Ph.D.
Director Designate, Division of Aging Biology, NIA
The Geroscience Hypothesis
10 minutes
Ana Maria Cuervo, M.D., Ph.D.
Robert and Renee Belfer Chair for the Study of Neurodegenerative Diseases, Albert Einstein College of Medicine
Research Spotlight
10 minutes
Tom Kalil, Chief Innovation Officer, Schmidt Futures
The Potential of a National Science and Technology Initiative in Geroscience
10 minutes
Mike Stebbins, President at Science Advisors, Former Assistant Director for Biotechnology, White House Office of Science and Technology Policy, Obama/Biden Administration
The Advanced Research Project Agency for Health: a Vehicle for High Risk, High Reward Investment in the Life Sciences
25 minutes
Luigi Ferrucci MD, PhD, Scientific Director, National Institute on Aging, National Institute of Health
White Paper Presentation: A Model Science and Technology Program
10 minutes
Break
This is your scheduled event description. Provide details about this specific activity or speaker including relevant information for your visitors. Add links, photos or a video for extra engagement!
July 12, 2025
Section 2: Bringing The Community to the Table: Addressing Disparities, Inclusion and Special Needs Populations in the Design And Delivery Of Science and Technology Programs
Schedule Item Body
10 minutes
Patricia Jones DrPH, MPH, MS,
Director, Office of Special Populations NIA/NIH
The NIA Approach to Health Disparities
10 minutes
Rory A. Cooper, PhD,
FISA/PVA Distinguished Professor, University of Pittsburgh(Pitt)
Aging with Disability
10 mInutes
Beth Calhoun, PhD, Professor Associate Dean for Population Health, Professor of Population Health, University of Kansas School of Medicine
The Demographics of Aging
July 12, 2025
Section 3: New Drug Development and the FDA
Schedule Item Body
5 minutes
G. Alexander Fleming, MD, Executive Chairman, Kinexium
Introduction of Elis Unger, MD
25 Minutes
Ellis F. Unger, MD, Director of the Office of Drug Evaluation-I, Office of New Drugs, Center for Drug Evaluation and Research, U.S. FDA
Pharmaceutical Development Targeting the Biology of Aging:
The FDA Perspective Remarks
10 Minutes
Q&A
Schedule Item Body
3 minutes
William K. Smith MD
Thank You and Next Steps